Evidence map›Paper›PMID 33948372›Full record

ArticleAmerican journal of cancer research2021

Low miR-16 expression induces regulatory CD4

Tao Zhu, Zhijie Lin, Sen Han, Yingying Wei, Guotao Lu, Yu Zhang, Weiming Xiao, Zhengbing Wang, Xiaoqin Jia, Weijuan Gong

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tao ZhuDepartment of Immunology, School of Medicine, Yangzhou University Yangzhou 225001, Jiangsu Province, P. R. China.
Zhijie LinDepartment of Immunology, School of Medicine, Yangzhou University Yangzhou 225001, Jiangsu Province, P. R. China.
Sen HanDepartment of Immunology, School of Medicine, Yangzhou University Yangzhou 225001, Jiangsu Province, P. R. China.
Yingying WeiJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225001, Jiangsu Province, P. R. China.
Guotao LuDepartment of Gastroenterology, Affiliated Hospital, Yangzhou University Yangzhou 225001, Jiangsu Province, P. R. China.
Yu ZhangJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225001, Jiangsu Province, P. R. China.
Weiming XiaoJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225001, Jiangsu Province, P. R. China.
Zhengbing WangJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225001, Jiangsu Province, P. R. China.
Xiaoqin JiaJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases Yangzhou 225001, Jiangsu Province, P. R. China.
Weijuan GongDepartment of Immunology, School of Medicine, Yangzhou University Yangzhou 225001, Jiangsu Province, P. R. China.
Integrated Chinese Medicine (China) · CNNorthern Jiangsu People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiR-15a/16 is a member of the miRNA cluster that exhibits tumor suppression and immune modulation via targeting multiple genes. Decreased miR-15a/16 expression is involved in many cancer cells. Here, miR-16 had decreased expression in NK1.1

Indexed as

CD4+ T cellcolorectal cancermiR-15a/16NKG2Dregulation

Identifiers

PMID33948372
PMCPMC8085839
OpenAlexW3157855560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.